```html

Chronic Renal Failure (Chronic Kidney Disease)

Overview

Chronic renal failure, more formally called chronic kidney disease (CKD), is a progressive loss of kidney function that persists for at least three months. The kidneys are unable to filter waste products, balance electrolytes, and regulate fluid volume as efficiently as they should. Over time, this can lead to the accumulation of toxins in the blood, anemia, bone disease, cardiovascular complications, and, ultimately, end‑stage renal disease (ESRD) requiring dialysis or transplantation.

Who it affects: CKD can develop at any age, but it is most common in adults over 45 years. Women are slightly more likely to be diagnosed, while men progress to ESRD more rapidly.

Prevalence (2023 data):

• Approximately 37 million adults in the United States (≈15% of the adult population) have CKD (CDC).
• Globally, the WHO estimates 850 million people (≈10% of the world population) have some stage of CKD.
• Progression to ESRD occurs in about 2–3% of individuals with CKD each year.

Many people are unaware they have CKD because early stages are often asymptomatic. Early detection through routine screening is crucial.

Symptoms

Symptoms usually appear once kidney function falls below 30 % of normal (stage 4). Early CKD may have none at all.

General symptoms

• Fatigue or weakness – due to anemia and toxin buildup.
• Decreased appetite, nausea, or vomiting – uremic toxins irritate the gastrointestinal tract.
• Unexplained weight loss.

Urinary changes

• Increased frequency (especially at night – “nocturia”).
• Decreased urine output or, paradoxically, increased volume in early disease.
• Foamy or bubbly urine – indicates proteinuria.
• Blood in the urine (hematuria) – may be gross or microscopic.

Fluid‑related symptoms

• Edema – swelling of ankles, feet, hands, or face.
• Shortness of breath – fluid accumulation in lungs (pulmonary edema).

Metabolic & endocrine symptoms

• Itching (pruritus) – caused by phosphate retention.
• Muscle cramps or twitching – electrolyte imbalances (especially low calcium, high phosphorus).
• Bone pain or fractures – renal osteodystrophy.
• Dry, itchy skin and changes in skin color.

Cardiovascular symptoms

• High blood pressure that is difficult to control.
• Chest pain or palpitations – may signal fluid overload or electrolyte disturbances.

Neurological symptoms

• Difficulty concentrating or memory problems (often described as “brain fog”).
• Tremors or seizures – severe electrolyte shifts.

Causes and Risk Factors

CKD is rarely caused by a single event; it usually results from chronic damage to the kidney’s filtering units (nephrons). The two most common underlying diseases are:

1. Diabetes Mellitus

• High blood glucose damages the glomeruli (diabetic nephropathy).
• Accounts for ~44 % of CKD cases in the U.S. (NIH).

2. Hypertension (High Blood Pressure)

• Elevated pressure injures blood vessels within the kidneys.
• Responsible for ~28 % of CKD cases.

Other notable causes

• Glomerulonephritis – inflammation of the glomeruli (autoimmune, infections).
• Polycystic kidney disease – genetic condition leading to cyst formation.
• Obstructive uropathy – kidney stones, enlarged prostate, or tumors blocking urine flow.
• Recurrent urinary tract infections, especially in children.
• Nephrotoxic drugs – NSAIDs, certain antibiotics, contrast agents.
• Systemic diseases – lupus, Sjögren’s syndrome, vasculitis.

Risk factors

• Age > 45 years
• Family history of CKD or diabetes
• African American, Hispanic, Native American, or Asian ancestry (higher prevalence)
• Obesity (BMI ≥ 30 kg/m²)
• Smoking
• High‑salt diet
• Chronic use of NSAIDs or herbal supplements containing aristolochic acid

Diagnosis

Diagnosis rests on evidence of kidney damage and/or reduced glomerular filtration rate (GFR) persisting ≥3 months.

Key laboratory tests

• Serum creatinine & estimated GFR (eGFR) – the cornerstone of staging CKD.
• Urine albumin‑to‑creatinine ratio (UACR) – detects proteinuria; ≥30 mg/g signals kidney damage.
• Blood urea nitrogen (BUN) – rises as kidneys fail.
• Electrolytes, calcium, phosphate, bicarbonate – monitor metabolic complications.
• Complete blood count – assesses anemia.

Imaging studies

• Renal ultrasound – evaluates kidney size, cysts, obstruction.
• CT or MRI – reserved for complex anatomy, stones, or suspected tumors.

Specialized assessments

• Kidney biopsy – indicated when the underlying cause is unclear (e.g., suspected glomerulonephritis).
• 24‑hour urine collection – precise measurement of protein excretion.

Staging (KDIGO 2022) based on eGFR

Stage	eGFR (mL/min/1.73 m²)	Clinical implications
1	≥90 (with evidence of kidney damage)	Usually asymptomatic; focus on risk factor control.
2	60–89	Monitor progression; treat underlying disease.
3a	45–59	Increased risk of cardiovascular events.
3b	30–44	Begin preparations for possible dialysis.
4	15–29	High risk of complications; referral to nephrology.
5	<15 or on dialysis	End‑stage renal disease – dialysis or transplant needed.

Treatment Options

Treatment aims to slow progression, manage complications, and maintain quality of life.

1. Medications

• ACE inhibitors or ARBs – lower intraglomerular pressure, reduce proteinuria (recommended for stages 1‑4).
• Blood pressure agents – target <130/80 mmHg (ACC/AHA guideline).
• Blood sugar control – SGLT2 inhibitors (e.g., dapagliflozin) have been shown to slow CKD progression even in non‑diabetics (KDIGO 2022).
• Phosphate binders – calcium acetate, sevelamer to control hyperphosphatemia.
• Vitamin D analogs – calcitriol or paricalcitol for secondary hyperparathyroidism.
• Erythropoiesis‑stimulating agents (ESAs) – treat anemia when hemoglobin <10 g/dL.
• Diuretics – manage fluid overload and edema.
• Potassium binders – patiromer or sodium zirconium cyclosilicate for hyperkalemia.

2. Lifestyle & Dietary Modifications

• Low‑sodium diet – <1500–2000 mg/day.
• Protein moderation – 0.6‑0.8 g/kg body weight daily (unless on dialysis).
• Phosphorus restriction – limit dairy, nuts, processed foods; aim <800–1000 mg/day.
• Potassium management – individualized; high‑potassium foods (bananas, oranges) may need limiting.
• Fluid intake – tailored to urine output and edema status; often 1.5‑2 L/day.
• Smoking cessation and regular aerobic exercise (≥150 min/week).

3. Procedural Interventions

• Renal replacement therapy (RRT) – dialysis (hemodialysis or peritoneal) when eGFR <15 mL/min/1.73 m² and symptomatic.
• Kidney transplantation – preferred long‑term solution; improves survival compared with dialysis.
• Management of complications – e.g., parathyroidectomy for refractory secondary hyperparathyroidism.

Living with Chronic Renal Failure

Adapting daily life can reduce symptoms and slow disease progression.

Medication adherence

• Use a weekly pill organizer.
• Set alarms or phone reminders.
• Keep a medication list for every healthcare visit.

Dietary planning

• Work with a renal‑dietitian to create individualized meal plans.
• Read food labels for sodium, potassium, and phosphate additives.
• Choose fresh over processed foods; rinse canned vegetables to lower sodium.

Fluid management

• Weigh yourself daily; a gain of >2 lb in 24 hrs may indicate fluid retention.
• Follow your nephrologist’s fluid limit.

Physical activity

• Low‑impact activities (walking, swimming, stationary bike) improve cardiovascular health.
• Avoid extreme dehydration; sip water per your fluid prescription.

Monitoring & follow‑up

• Routine labs every 3‑6 months (eGFR, electrolytes, urine protein).
• Annual eye exam (diabetes) and foot exam (peripheral neuropathy).
• Vaccinations: flu annually, COVID‑19 booster, hepatitis B, and pneumococcal vaccine.

Emotional & social support

• Join CKD support groups (online or local).
• Consider counseling to manage anxiety or depression, which are common.
• Inform family and coworkers about your condition and any accommodations needed.

Prevention

While some risk factors (age, genetics) are non‑modifiable, many steps can markedly lower CKD risk.

• Control blood pressure – maintain <130/80 mmHg; use ACE‑I/ARB when indicated.
• Manage blood glucose – target HbA1c <7 % (individualized).
• Maintain a healthy weight – BMI 18.5‑24.9 kg/m².
• Adopt a kidney‑friendly diet – DASH or Mediterranean patterns with reduced sodium.
• Stay hydrated, but avoid excessive fluids – 1.5–2 L/day for most adults.
• Avoid nephrotoxic substances – limit NSAIDs, watch for contrast dye usage.
• Quit smoking – reduces cardiovascular and renal risk.
• Regular screening – annual eGFR and urine albumin checks for people with diabetes, hypertension, or a family history of CKD.

Complications if Untreated

If CKD progresses unchecked, several serious complications can arise:

• End‑stage renal disease (ESRD) – requiring lifelong dialysis or transplantation.
• Cardiovascular disease – CKD triples the risk of heart attack and stroke (Mayo Clinic).
• Anemia – due to reduced erythropoietin production.
• Bone and mineral disorder – hyperphosphatemia, secondary hyperparathyroidism, renal osteodystrophy.
• Electrolyte disturbances – hyperkalemia, metabolic acidosis.
• Fluid overload – pulmonary edema, hypertension.
• Peripheral neuropathy – uremic toxins affect nerves.
• Pregnancy complications – preeclampsia, preterm birth.
• Increased infection risk – impaired immune function.

When to Seek Emergency Care

---

Sources: Mayo Clinic, Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), World Health Organization (WHO), Cleveland Clinic, KDIGO Clinical Practice Guidelines 2022, American College of Cardiology/American Heart Association (ACC/AHA) hypertension guideline 2023.

```